6
070
J. Am. Chem. Soc. 1996, 118, 6070-6071
Solid-Phase Unnatural Peptide Synthesis (UPS)
,
†
†
Martin J. O’Donnell,* Changyou Zhou, and
William L. Scott*,
‡
Department of Chemistry, Indiana UniVersity-Purdue
UniVersity at Indianapolis, Indianapolis, Indiana 46202
Technology Core Research, Lilly Research Laboratories
Lilly Corporate Center, Eli Lilly and Company
Indianapolis, Indiana 46285
ReceiVed January 16, 1996
Solid-phase peptide synthesis (SPPS) has evolved into a
1,2
powerful synthetic method since it was first reported in 1963.
Figure 1. General scheme for solid-phase unnatural peptide synthesis
UPS). Abbreviations: shaded circle ) resin (Merrifield, Wang,...);
) O, NH, peptide, etc.; PG ) protecting group; UN ) unnatural
It is considered the method of choice for the automated
preparation of peptides in numerous laboratories around the
world. SPPS is now being used to rapidly synthesize peptides
in a combinatorial fashion.3 Peptide libraries constructed from
naturally occurring amino acids have been widely used to screen
for biological activity. However, increased activity, bioavail-
ability, and degradative resistance often require incorporation
(
X
n
side chain (an electrophile, such as an alkyl halide UN-X, is used in
the alkylation step); Y ) natural amino acid or peptide or N-protected
terminus; Y* ) resin-free N-terminal end; X * ) resin-free C-terminal
n
end. For experimental conditions, see ref 9.
4
of unnatural residues in the peptide framework. Currently, most
9
In this procedure, three new steps (Figure 1, reactions in
box), activation (C), alkylation (D), and imine hydrolysis of
the resin-bound Schiff base (E), have been added to the normal
SPPS sequence involving deprotection (B) and coupling (F or
G) steps. Following step E in the loop a number of options are
possible: repeat the steps in the UPS to add another unnatural
residue to the growing peptide chain (step F), couple a natural
amino acid or other residue via normal solid-phase methodology
(step G), or protect the free amino group subsequent to other
reactions on the resin-bound product (step H). Finally, the
product is cleaved from the resin (step I).
synthetic routes to modified peptides incorporate the individually
prepared unnatural amino acid residue5 by normal peptide
synthesis.
A more direct and flexible method for the preparation of
peptides containing modified amino acid residues would be to
build the new side chains onto the growing peptide chain during
the peptide synthesis.6 One major obstacle must be overcome
to practically realize this goal: a mild methodology of carbon-
carbon bond formation on solid phase is needed to selectiVely
introduce the side chain at the R-carbon of a particular residue
in the growing peptide chain. To accomplish this we have
adapted the solution phase chemistry employed in the selective
CR-Câ bond formation reaction of Schiff base activated amino
acids7 and peptides8 to a new methodology: “solid-phase
unnatural peptide synthesis” or solid-phase UPS (Figure 1).
To simplify analysis in the initial resin-bound alkylations, a
known dipeptide [(D,L)-Phe-Leu] was constructed by backbone
alkylation of a Gly-Leu derivative (Figure 2). The benzophe-
†
Indiana University-Purdue University at Indianapolis.
‡
Eli Lilly and Company.
(1) (a) Merrifield, R. B. J. Am. Chem. Soc. 1963, 85, 2149-2154. (b)
Figure 2. Alkylation step in solid-phase UPS.
Merrifield, R. B. Science 1986, 232, 341-347.
2) (a) Lloyd-Williams, P.; Albericio, F.; Giralt, E. Tetrahedron 1993,
9, 11065-11133. (b) Benz, H. Synthesis 1994, 337-358.
3) (a) Ellman, J. A. CHEMTRACTS: Org. Chem. 1995, 8, 1-4. (b)
Pirrung, M. C. Ibid. 1995, 8, 5-12. (c) Czarnik, A. W. Ibid. 1995, 8, 13-
(
4
none imine of Gly-Leu-Merrifield resin (1) was conveniently
prepared from TFA‚H2N-Gly-Leu-resin by reaction with
(
10,11
benzophenone imine.
After unsuccessful attempts to effect
1
8. (d) Mitscher, L. A. Ibid. 1995, 8, 19-25. (e) Pinilla, C; Appel, J.;
Blondelle, S.; Dooley, C.; D o¨ rner, B.; Eichler, J.; Ostresh, J.; Houghten,
R. A. Biopolymers 1995, 37, 221-240. (f) Schultz, P. G.; Lerner, R. A.
Science 1995, 269, 1835-1842. (g) Terrett, N. K.; Gardner, M.; Gordon,
D. W.; Kobylecki, R. J.; Steele, J. Tetrahedron 1995, 51, 8135-8173.
benzylation of 1 with melted KOH/K2CO3 (incomplete conver-
8
12
sion) or strong ionic bases (racemization of peptides),
simultaneous deprotonation and alkylation of 1 with benzyl
bromide was accomplished using the organic-soluble, nonionic
(4) (a) Zuckermann, R. N.; Kerr, J. M.; Kent, S. B. H.; Moos, W. H. J.
Am. Chem. Soc. 1992, 114, 10646-10647. (b) Kerr, J. M.; Banville, S. C.;
Zuckermann, R. N. J. Am. Chem. Soc. 1993, 115, 2529-2531. (c) Karle,
I. L.; Rao, R. B.; Prasad, S.; Kaul, R.; Balaram, P. J. Am. Chem. Soc. 1994,
(9) Reaction conditions: C, (a) TFA‚H2N-Gly-Merrifield resin,
Ph2CdNH (1.5 equiv)/1-N-methyl-2-pyrrolidinone (NMP), overnight; (b)
H2N-Gly-Wang resin, Ph2CdNH (1.5 equiv)/AcOH (1.3 equiv)/NMP,
overnight. D, UN-X (2.0 equiv)/2-tert-butylimino-2-diethylamino-1,3-
dimethylperhydro-1,3,2-diazaphosphorine (BEMP) (2.0 equiv)/NMP, over-
night. E, (a) Merrifield resin, 1 N aqueous HCl/THF (3/7), overnight, then
DIEA (10%)/NMP; (b) Wang resin, 1 N aqueous NH2OH‚HCl/THF (3/7),
5 h, then DIEA (10%)/NMP. H, (a) Merrifield resin, Boc2O (3.0 equiv)/
NMP or CbzOSu (3.0 equiv)/NMP; (b) Merrifield or Wang resin, FmocCl
(3.0 equiv)/DIEA (6.0 equiv)/NMP. I, (a) Merrifield or Wang resin, Ti-
(OEt)4 (5.0 equiv)/allyl alcohol, 120 °C, pressure tube, 2 h; (b) only for
Wang resin, TFA (95%)/H2O, 5 h.
1
16, 10355-10361. (d) Cornish, V. W.; Mendel, D.; Schultz, P. G. Angew.
Chem., Int. Ed. Engl. 1995, 34, 621-633. (e) Voyer, N.; Lamothe, J.
Tetrahedron 1995, 51, 9241-9284.
(5) (a) Duthaler, R. O. Tetrahedron 1994, 50, 1539-1650. (b) Williams,
R. M. in AdVances in Asymmetric Synthesis; Hassner, A., Ed.; Jai Press
Inc.: Greenwich, CT, 1995; Vol. 1, pp 45-94. (c) Ojima, I. in AdVances
in Asymmetric Synthesis; Hassner, A., Ed.; Jai Press Inc.: Greenwich, CT,
1
995; Vol. 1, pp 95-146.
6) CR-C bond formation in protected peptides: reference 8, footnote
. (a) Ager, D. J.; Froen, D. E.; Klix, R. C.; Zhi, B.; McIntosh, J. M.;
(
1
Thangarasa, R. Tetrahedron 1994, 50, 1975-1982. (b) Steglich, W.; J a¨ ger,
M.; Jaroch, S.; Zistler, P. Pure Appl. Chem. 1994, 66, 2167-2170. (c)
Kazmaier, U. J. Org. Chem. 1994, 59, 6667-6670. (d) Seebach, D.; Beck,
A. K.; Studer, A. In Modern Synthetic Methods 1995; Ernst, B., Leumann,
C., Eds.; VCH: Weinheim, 1995; Vol. 7, pp 1-178.
(10) O’Donnell, M. J.; Polt, R. L. J. Org. Chem. 1982, 47, 2663-2666.
(11) Other recent applications involving resin-bound imines: Murphy,
M. M.; Schullek, J. R.; Gordon, E. M.; Gallop, M. A. J. Am. Chem. Soc.
1995, 117, 7029-7030.
(12) Solution-phase model alkylation (solution UPS) of the dipeptide
Schiff base ester Ph2CdNCH2CO-Phe-OMe with 4-bromobenzyl bromide
showed that 15-68% racemization of the pre-existing chiral center was
observed with potassium tert-butoxide, 9-lithium fluorene, or lithium 2,6-
di-tert-butyl-4-methylphenoxide.
(
7) O’Donnell, M. J.; Wu, S.; Huffman, J. C. Tetrahedron 1994, 50,
507-4518.
8) O’Donnell, M. J.; Burkholder, T. P.; Khau, V. V.; Roeske, R. W.;
Tian, Z. Pol. J. Chem. 1994, 68, 2477-2488.
4
(
S0002-7863(96)00124-2 CCC: $12.00 © 1996 American Chemical Society